NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/28/2024
Back to search
Official data from USPTO
AMPTEC
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
AMPTEC
ST13
US500000097712953Class
1, 40, 42
Filing
97712953
Registration
7395725
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
21
Latest update
05/28/2024
Trademark type
Word
Nice classes
1, 40, 42
Filing date
12/12/2022
Registration date
05/28/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/28/2024
Last transaction
05/28/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
99
Owner location
64293 Darmstadt, DE
Examiner
SPARACINO, MARK V
Law office
L30
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
MERCK KGAA
Representatives
William C. Wright EPSTEIN DRANGEL LLP
Technical classification
Nice Classes
Class 1Class 40Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemical and biochemical products for industrialscientific or therapeutic purposes in the fields of pharmacybiologymolecular biologybiochemistrybiotechnology and chemistryincluding food chemistrychemicals for use in biotechnological product development; Chemical preparations and reagentsother than for medical or veterinary purposesin particularnucleic acid modifying enzymes and nucleic acid reagents; Diagnostic preparations other than for medical or veterinary purposes for molecular biology research and diagnosticsincluding research and diagnostic preparations containing the aforementioned reagents alone or in combination with other reagents as assemblies in the nature of consisting primarily of buffersreagent components as part of kits or assemblies containing nucleic acidsfor the processing or therapeutic application of pathogenic and non-pathogenic microorganisms and of nucleic acid molecules
Class 40
Custom manufacture of biopharmaceuticals; Custom manufacture of pharmaceuticals
Class 42
Quality control for othersconducting of quality control tests for manufacture of nucleic acids for research and therapeutic use; Consumer product safety testing for manufacture of nucleic acids for research and therapeutic use; Process monitoring for quality assurance for manufacture of nucleic acids for research and therapeutic use; Product quality testing services for manufacture of nucleic acids for research and therapeutic use; Product safety testing services for manufacture of nucleic acids for research and therapeutic use; Quality control for othersproviding quality assurance services for manufacture of nucleic acids for research and therapeutic use; Quality control of goods and services for manufacture of nucleic acids for research and therapeutic use; Scientific and technological servicestesting in the field of manufacture of nucleic acids for research and therapeutic use; Testing of pharmaceuticals; Testing of biologics in the nature of pharmaceuticals; Testing of biopharmaceuticals; Testing of raw materials; Development of pharmaceuticals preparations and medicinesmanufacture of nucleic acids for therapeutic use; Pharmaceutical drug development services for manufacture of nucleic acids for therapeutic use
Publications
History of USPTO decisions and trademark events.
21 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
05/28/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/12/2024
PUBO
PUBLISHED FOR OPPOSITION
03/12/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/21/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/21/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/06/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/05/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
02/05/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/05/2024
DOCK
ASSIGNED TO EXAMINER
01/11/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/10/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/10/2024
ALIE
ASSIGNED TO LIE
01/10/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/15/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/07/2023
GNRT
NON-FINAL ACTION E-MAILED
06/07/2023
CNRT
NON-FINAL ACTION WRITTEN
06/07/2023
DOCK
ASSIGNED TO EXAMINER
05/18/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/08/2023
NWAP
NEW APPLICATION ENTERED
12/15/2022
Continuous trademark protection
Get notified about every new filing that threatens AMPTEC or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.